William Blair Investment Management LLC Cuts Stock Holdings in Humana Inc. $HUM

Key Points

• William Blair Investment Management LLC reduced its holdings in Humana Inc. by 21.8%, selling 3,017 shares to hold a total of 10,811 shares valued at approximately $2.64 million.
• Analysts have varying opinions on Humana's stock, with Wolfe Research raising its target price from $283.00 to $313.00 while Barclays decreased it from $315.00 to $245.00, resulting in a consensus rating of "Hold".
• Humana reported earnings of $6.27 per share for the last quarter, slightly missing expectations, although it experienced a 9.6% revenue increase year-over-year with total revenue reaching $32.39 billion.

William Blair Investment Management LLC reduced its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 21.8% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,811 shares of the insurance provider's stock after selling 3,017 shares during the period. William Blair Investment Management LLC's holdings in Humana were worth $2,643,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in HUM. Revolve Wealth Partners LLC purchased a new position in Humana during the fourth quarter worth about $202,000. GAMMA Investing LLC grew its position in Humana by 54.9% during the first quarter. GAMMA Investing LLC now owns 2,952 shares of the insurance provider's stock worth $781,000 after buying an additional 1,046 shares during the period. Wealth Enhancement Advisory Services LLC grew its position in Humana by 144.4% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 15,734 shares of the insurance provider's stock worth $4,163,000 after buying an additional 9,296 shares during the period. Janney Montgomery Scott LLC acquired a new position in Humana during the first quarter worth about $1,309,000. Finally, Garde Capital Inc. acquired a new position in Humana during the first quarter worth about $36,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have weighed in on HUM. Wolfe Research upped their target price on shares of Humana from $283.00 to $313.00 and gave the stock an "outperform" rating in a research report on Monday, October 6th. Weiss Ratings restated a "sell (d+)" rating on shares of Humana in a research report on Wednesday, October 8th. Barclays lowered their target price on shares of Humana from $315.00 to $245.00 and set an "equal weight" rating on the stock in a research report on Friday, October 3rd. Bank of America upped their target price on shares of Humana from $280.00 to $300.00 and gave the stock a "neutral" rating in a research report on Friday, October 10th. Finally, Wall Street Zen lowered shares of Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Eight equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Humana has a consensus rating of "Hold" and an average price target of $297.58.

Humana Stock Up 3.2%

Shares of NYSE HUM opened at $283.75 on Tuesday. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The firm's 50 day moving average price is $280.87 and its 200 day moving average price is $258.35. The firm has a market cap of $34.13 billion, a P/E ratio of 21.78, a price-to-earnings-growth ratio of 1.61 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. During the same quarter last year, the business posted $6.96 EPS. The firm's revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. Humana's dividend payout ratio (DPR) is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.